These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10939592)

  • 1. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
    Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV
    Cell Growth Differ; 2000 Jul; 11(7):385-93. PubMed ID: 10939592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling.
    Glover S; Nathaniel R; Shakir L; Perrault C; Anderson RK; Tran-Son-Tay R; Benya RV
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1274-82. PubMed ID: 15890713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407.
    Matkowskyj KA; Keller K; Glover S; Kornberg L; Tran-Son-Tay R; Benya RV
    J Histochem Cytochem; 2003 Aug; 51(8):1041-8. PubMed ID: 12871985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans.
    Carroll RE; Matkowskyj KA; Chakrabarti S; McDonald TJ; Benya RV
    Am J Physiol; 1999 Mar; 276(3):G655-65. PubMed ID: 10070042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties.
    Glover S; Delaney M; Dematte C; Kornberg L; Frasco M; Tran-Son-Tay R; Benya RV
    J Cell Physiol; 2004 Apr; 199(1):77-88. PubMed ID: 14978737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
    Matusiak D; Glover S; Nathaniel R; Matkowskyj K; Yang J; Benya RV
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G718-28. PubMed ID: 15528253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
    Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
    Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.
    Glover SC; Tretiakova MS; Carroll RE; Benya RV
    Mol Carcinog; 2003 May; 37(1):5-15. PubMed ID: 12720295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
    Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR
    Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.
    Taglia L; Matusiak D; Matkowskyj KA; Benya RV
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G182-90. PubMed ID: 16920698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines.
    Carroll RE; Ostrovskiy D; Lee S; Danilkovich A; Benya RV
    Mol Pharmacol; 2000 Sep; 58(3):601-7. PubMed ID: 10953054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S; Guo YS; Townsend CM; Singh P
    Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney.
    Dumesny C; Whitley JC; Baldwin GS; Giraud AS; Shulkes A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F578-85. PubMed ID: 15140764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
    Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
    Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer.
    Jensen JA; Carroll RE; Benya RV
    Peptides; 2001 Apr; 22(4):689-99. PubMed ID: 11311741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation.
    Lin Y; Jian X; Lin Z; Kroog GS; Mantey S; Jensen RT; Battey J; Northup J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1053-62. PubMed ID: 10945859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
    Staley CA; Parikh NU; Gallick GE
    Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.